Closing the data loop in AI-driven drug discovery

Read full story on MIT Tech Review AI
Share
Closing the data loop in AI-driven drug discovery
AI disclosure

Summary

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…

Original reporting

Open original source

Related coverage

Read full article on MIT Tech Review AI

Get the AFBytes Brief

Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime.